Introduction
Mutations of skeletal muscle sodium channel a subunit (SCN4A) gene are associated with a group of allelic diseases, including periodic paralysis, paramyotonia congenital, sodium channel myotonia, and congenital myasthenic syndrome. 1 Periodic paralysis is characterized by episodic attacks of flaccid weakness with the fluctuation of serum potassium, which are usually limited to skeletal muscles owing to tissue specific expression of channel isoforms. 2 However, periodic paralysis is occasionally concomitant with cardiac arrhythmia, essential tremor, and epilepsy. Here we described a case of normokalemic periodic paralysis with involuntary movements and generalized epilepsy associated with two novel heterozygous missense mutations in SCN4A gene.
Case report
The patient gave written informed consent for this case study, approved by Institute ethical committee. A 19-year-old man suffered from paroxysmal limb shake since one year old. The manifestation was prominent in his right hand, and got more serious when he was nervous. He experienced generalized tonicclonic seizure at the age of 10. The electroencephalogram (EEG) indicated epileptic discharge, but cerebral MRI showed no abnormalities. Since similar seizure occurred 5 times in a month, the boy was administrated valproic acid 600 mg daily. The seizures gradually disappeared in following two years, while the limb shake still persisted. At the age of 13, he started to have episodic muscle weakness, occasionally with postcritic myalgia. The attacks were usually triggered by cold or rest after strenuous exercise. The frequency of attacks was four times a year and the duration ranged from several hours to one day, while serum potassium level was normal. The episodic weakness was irresponsive to oral potassium administration. Nobody in his family had similar paralytic episodes or other neural disorders. When he came to our hospital, the attacks happened once a week, accompanied with postcritic diarrhea.
Neurological examination revealed muscle strength 4+/5 (MRCS, grades 0-5) grade in the right limbs. Right thigh was slight atrophy, while right arm was stiffness and hypertrophy. No muscle cramps could be elicited by palpating muscles. There are no abnormalities in cognitive function. Serum creatine kinase was 2500 IU/L (normal 24-195 IU/L). The potassium and thyroid hormones levels were normal. Electrocardiogram showed sinus arrhythmia. Echocardiography, electroencephalogram and cerebral MRI were normal. Electromyogram showed myopathic changes. A long exercise test indicated that the compound muscle action potential (CMAP) amplitude was progressively decreased by 62.3% over 50 min after finishing the exercise and persisted at this low level for 2 h.
The striking features of muscle biopsy were some vacuoles located around subsarcolemmal (Fig. 1a and c) . Some vacuoles were filled with periodic acidic schiff (PAS) positive materials (Fig. 1b) , while other vacuoles were spared (Fig. 1d) . Ultrastructural examinations confirmed numerous glycogen granules deposited under the subsarcolemmal (Fig. 1e) . A few dilated myotubules were observed (Fig. 1f) .
Genomic DNA was extracted from blood samples of the patient. Coding exons of the SCN4A gene were amplified using polymerase chain reaction (PCR) with intronic primers. After purification, PCR products were directly sequenced with an ABI 3730 DNA Analyzer (Applied Biosystems, Inc., CA, USA). Genetics screening found two novel missense mutations (p.Glu974Asp and p.Lys1126Ile) in SCN4A gene (Fig. 2a and b) . However, no mutations were found in the acid maltase, myophosphorylase, muscle isoform of phosphofructokinase, sodium channel a1 subunit (SCN1A), a2 subunit (SCN2A) and b1 subunit (SCN1B) genes (data not shown). The two mutations are absent in 100 healthy Chinese subjects.
Discussion
An interesting issue raised by this patient is the relationship between periodic paralysis and neural disorders. The episodic weakness was onset from childhood with normakalemia during the attack and persistent CAMP decrease in the long exercise test. The clinical pictures are in accordance with normakalemic periodic paralysis (NormPP), although NormPP is believed as a variant of hyperkalemic periodic paralysis. 3 On the other hand, paroxysmal limb shake and generalized epilepsy indicated the lesions in central nervous system. Accordingly, the syndromes of this case seemed to be explained by defects in genes associated with channelopathy. However, the clinical phenotypes in association with the ion channel genes mutations are usually limited to a single organ owing to tissue specific expression of channel isoforms. For example, mutations in cerebral SCN1A, SCN2A and SCN1B genes have been associated with four idiopathic epilepsy syndromes, while mutations of SCN4A are linked to muscular disorders. 4 Although hypokalemic periodic paralysis with multiplex epilepsies has been occasionally described, clinical and genetic findings demonstrate that epileptic activities were independent of periodic paralysis. Therefore, the correlation between NormPP, involuntary movements and generalized epilepsy in this case is still open to discuss. In this report, we identified two novel SCN4A mutations and excluded gene mutations associated with glycogen storage disease and epilepsy-causing sodium channels. The p.Lys1126Ile mutation is located in the S4 segment of domain III (DIIIS4) of SCN4A protein, which is completely conserved in sodium channels of different species. The positive residues in the S4 segments serve as voltagesensors of the voltage dependent sodium channels. Accordingly, the p.Lys1126Ile mutation is closely related to periodic paralysis. However, the status of p.Glu974Asp mutation remained elusive, which might play a synergetic role for p.Lys1126Ile mutation. The pathogenic mechanism of the novel mutations should be further elucidated.
In conclusion, a double mutation identified in one case is a rare phenomenon for a dominant inherited disease. The findings expand the mutation spectrum of SCN4A gene, and our case indicates that normakalemic periodic paralysis may be associated with cerebral dysfunctions.
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